Abiopharma

New Form 8-K - Carisma Therapeutics Inc. Filed: 2025-06-23 AccNo: 0001104659-25-061397 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits